Cardiovascular burden in systemic sclerosis: QRISK3 versus Framingham for risk estimation.

Marco Di BattistaSimone BarsottiAlessandra Della RossaMarta Mosca

Published in: Modern rheumatology (2021)

QRISK3 classifies more SSc patients at high risk to develop CV diseases than Framingham, reflecting the influence of some SSc-specific characteristics. If its predictive accuracy were prospectively verified, the use of QRISK3 as a tool in the early detection of SSc patients at high CV risk should be recommended.

Keyphrases

systemic sclerosis
end stage renal disease
interstitial lung disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
patient reported outcomes